💨 Abstract

The U.S. government has advised American travelers aged 60 and older to avoid Ixchiq, a chikungunya vaccine, due to potential side effects. The CDC and FDA are investigating cases of heart or brain symptoms in older patients post-vaccination. Previously, the vaccine was recommended for U.S. adults traveling to affected countries. Additionally, a second vaccine, Vimkunya, may be available for those aged 12 and older. Both U.S.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖